Today: 13 May 2026
Above Food Ingredients (ABVE) Stock Jumps as Delayed 20-F Filing Keeps Investors on Edge
4 May 2026
2 mins read

Above Food Ingredients (ABVE) Stock Jumps as Delayed 20-F Filing Keeps Investors on Edge

Regina, Saskatchewan, May 4, 2026, 13:52 (CST)

Above Food Ingredients Inc. shares jumped roughly 33% Monday afternoon, surging on the Nasdaq despite no new filings or press releases from the food and agtech firm. The stock climbed to $0.7089 after starting the day at $0.54, hitting an intraday peak of $0.8297. Volume swelled to nearly 43.8 million shares.

This development lands as Above Food’s fiscal 2025 annual report remains outstanding. Back on April 20, the company pointed to an ongoing audit. Delays, it said, are partly the result of some subsidiaries heading into receivership—a process where a court-appointed receiver steps in to manage assets or operations.

Form 20-F serves as the main annual report for foreign private issuers listed in the U.S. According to SEC guidance, these issuers are usually required to submit the Form 20-F no later than four months following the close of their fiscal year.

Above Food filed its latest report with the SEC on April 21. The company’s news feed hasn’t changed since the April 20 update about its audit status, which remains the most recent headline. With that in mind, Monday’s price action didn’t follow any fresh company announcement—it looked to be a market move.

The move was notable compared to other food stocks. Beyond Meat edged up roughly 1.1%. Oatly slipped about 1.2%. Ingredion, which makes ingredients, dropped around 2.5% as of the afternoon. All told, action looked focused on Above Food, not a wider push for plant-based or ingredient names.

Earlier, Above Food struck a more upbeat note on timing. On March 27, Chief Executive and Executive Chairman Lionel Kambeitz told investors the company was “fully focused on resolving the final procedural items.” At that point, Above Food had announced its Form 20-F was ready to go, pending just third-party confirmations and a final review.

On April 20, the company pulled back a bit. Above Food said it couldn’t guarantee anything regarding fiscal 2025 performance or when the Form 20-F would land—not until the audit wrapped up and the independent auditor’s report came through.

Nasdaq compliance remains a drag here. Back in February, the company disclosed it got a staff determination letter from Nasdaq, citing non-compliance with Listing Rule 5250(c)(2) due to late interim financials for the six months ended July 31, 2025. At the time, Above Food said the notice carried no immediate impact.

Above Food, which bills itself as an ag and food tech player focused on plant-based protein supply chains and seed development, has pointed to the late filings as a barrier to wrapping up planned deals—Palm Global remains in the mix.

The risk is straightforward enough. Should the audit stretch out, or if the final numbers don’t line up with what investors are betting on, Monday’s gains might not stick around. Lingering Nasdaq compliance issues could also spoil the mood in a hurry. Back in March, the company flagged several possible hurdles for the deal: regulatory timelines, listing questions, integration snags, and plain old delays.

At the moment, Above Food’s narrative is shaped more by activity in a stock still waiting on certain filings than by any fresh business developments. The next significant milestone is still the fiscal 2025 Form 20-F. After that, interim statements—promised by the company—are expected once the annual report lands.

Stock Market Today

  • Anthropic Warns Against Tokenized Pre-IPO Shares Amid Price Turmoil
    May 13, 2026, 1:21 PM EDT. Anthropic, creator of AI model Claude, has declared tokenized products claiming access to its private shares are invalid. The company labeled unauthorized transfers through tokenized securities, forward contracts, or special purpose vehicles (SPVs) as "void," highlighting risks in crypto pre-IPO markets. Following the warning, PreStocks' tokenized Anthropic shares plunged nearly 50%, though other tokenized exposure forms showed less volatility. This follows a broader trend where several platforms offer pseudo exposure to high-profile private companies like OpenAI and SpaceX, despite transfer restrictions and regulatory concerns. Anthropic's firm stance underscores significant legal and structural risks linked to tokenized private equity instruments.

Latest articles

Ondas Stock on Watch After SkyLance Test and Mistral Share Filing Before Q1 Earnings

Ondas Stock on Watch After SkyLance Test and Mistral Share Filing Before Q1 Earnings

13 May 2026
Ondas Inc.’s Rotron Aerospace completed a firing demo of its SkyLance long-range one-way effector ahead of Ondas’s Q1 results release. Ondas shares fell 12 cents to $8.92 after the company filed for resale of 2.77 million shares tied to its $175 million Mistral acquisition. The Mistral deal boosted Ondas’s backlog to $457 million as of March 31. Rotron was acquired in March for $6.7 million cash and 3.33 million shares.
Gold Price Drop Deepens as Hot Inflation Shakes Fed Bets Before Trump-Xi Talks

Gold Price Drop Deepens as Hot Inflation Shakes Fed Bets Before Trump-Xi Talks

13 May 2026
Spot gold fell 0.6% to $4,686.99 an ounce Wednesday after U.S. inflation data fueled bets on higher-for-longer interest rates, pressuring bullion. U.S. gold futures edged up 0.2%. India raised gold and silver import tariffs to 15%, sending local gold futures up 7.2%. Treasury yields climbed toward their highest since July, adding further drag for gold.
UiPath Stock Drops as Its AI Agent Bet Hits a Hard Earnings Test

UiPath Stock Drops as Its AI Agent Bet Hits a Hard Earnings Test

13 May 2026
UiPath Inc. shares dropped 5.9% to $9.42 on Wednesday, with trading volume above 22 million, after the company launched a new integration for AI coding agents but investors waited for clearer demand signals ahead of its May 28 earnings call. UiPath reported fourth-quarter revenue of $481 million, up 14%, and reached full-year GAAP profitability for the first time.

Popular

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Cenovus Energy Stock Climbs Before Q1 Results as CIBC Puts MEG Deal in Focus
Previous Story

Cenovus Energy Stock Climbs Before Q1 Results as CIBC Puts MEG Deal in Focus

Sangamo Stock Jumps Before Nasdaq Exit: Why SGMO Investors Are Watching May 5
Next Story

Sangamo Stock Jumps Before Nasdaq Exit: Why SGMO Investors Are Watching May 5

Go toTop